Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.82 USD | -1.33% | -7.87% | -8.98% |
May. 01 | RBC Trims Exelixis' Price Target to $27 From $28, Outperform Rating Kept | MT |
Apr. 30 | Exelixis Q1 Non-GAAP Earnings, Revenue Rise; 2024 Revenue Guidance Maintained -- Shares Fall After Hours | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.98% | 6.44B | |
-2.20% | 103B | |
+6.87% | 101B | |
+4.19% | 23.07B | |
-12.31% | 22.23B | |
-4.83% | 18.05B | |
-39.98% | 17.18B | |
-11.35% | 16.94B | |
+5.97% | 14.07B | |
+37.14% | 12.35B |
- Stock Market
- Equities
- EXEL Stock
- News Exelixis, Inc.
- Wells Fargo Starts Exelixis at Overweight With $23 Price Target